Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanchez Quiroga (Plasencia, Spain), J. Masa Jiménez (Cáceres, Spain), B. Mohklesi (Chicago, United States of America), I. Benitez (Madrid, Spain), M. Mogollón (Cáceres, Spain), F. Gómez De Terreros (Cáceres, Spain), A. Romero (Sevilla, Spain), C. Caballero Eraso (Sevilla, Spain), M. Alonso Álvarez (Burgos, Spain), E. Ordax Carballo (Burgos, Spain), T. Gómez García (Madrid, Spain), M. González (Santander, Spain), S. López Martín (Madrid, Spain), J. Marín (Zaragoza, Spain), S. Marti (Barcelona, Spain), T. Diaz Cambriles (Madrid, Spain), E. Chiner (Alicante, Spain), C. Egea (Vitoria, Spain), J. Barca (Cáceres, Spain), F. Vázquez Polo (Las Palmas, Spain), M. Negrin (Las Palmas, Spain), M. Martel Escobar (Las Palmas, Spain), J. Corral (Cáceres, Spain). Long-term echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome. 2998

Member's Comments

No comment yet.

Related content which might interest you: Echocardiographic changes with positive airway pressure in obesity hypoventilation syndrome. Pickwick study Source: International Congress 2017 – CPAP therapy Year: 2017 Long-term positive airway pressure therapy in obesity hypoventilation syndrome. Cost study Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Obesity hypoventilation syndrome and neurocognitive function - impact of positive airway pressure therapy Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome? Source: Sleep and Breathing Conference 2021 Year: 2021 Effectiveness of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 682s Year: 2006 Long-term noninvasive positive pressure ventilation improves gas exchange and restrictive ventilatory pattern in obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 85s Year: 2005 Long term outcomes of noninvasive positive pressure ventilation for obesity hypoventilation syndrome Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Physiological differences in patients with kyphoscoliosis, post tuberculosis sequelae and obesity hypoventilation syndrome when starting long-term noninvasive positive pressure ventilation (NPPV) Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting Year: 2008 Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015 Elevated serum erythropoietin level in obesity hypoventilation syndrome patients improved by nasal positive pressure ventilation therapy Source: Eur Respir J 2002; 20: Suppl. 38, 101s Year: 2002 Beneficial effects of non-invasive mechanical ventilation in patients with obesity hypoventilation syndrome Source: Annual Congress 2009 - Noninvasive ventilation: new and old aspects Year: 2009 The Pickwick randomized clinical trial: long-term positive airway pressure therapy in obesity hypoventilation syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 564s Year: 2005 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea Year: 2006 Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015